Insulatard HM 100IU/ml Penfill contains Insulin Isophane at a concentration of 100 IU/ml and is indicated for the management of diabetes mellitus requiring insulin therapy. Insulin Isophane is an intermediate-acting insulin suspension designed to provide prolonged glycemic control by reducing blood glucose levels over an extended period. It is typically administered subcutaneously to patients with type 1 diabetes mellitus or type 2 diabetes mellitus when diet, exercise, and oral hypoglycemic agents alone do not provide adequate glycemic control. The onset of action is generally within 1 to 2 hours, with peak activity occurring between 4 to 12 hours post-injection, and duration lasting up to 24 hours. Insulatard HM Penfill is supplied in a cartridge format compatible with reusable insulin pens, facilitating accurate dosing and ease of administration. Dosage and timing should be individualized based on patient needs, blood glucose monitoring, and clinical response. Caution is advised to avoid hypoglycemia, and patients should be educated on recognizing and managing low blood sugar episodes. This product should be stored under recommended conditions to maintain potency and efficacy. Insulatard HM is an essential component in the comprehensive management of diabetes, contributing to improved glycemic control and reduction of long-term complications.